Drugs / Human menopausal gonadotrophin (HMG)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT02640976 Comparator | Jun 2013 → Jun 2015 | female infertility | Cairo University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human menopausal gonadotrophin (HMG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02640976 ↗ |
| Route | Intramuscular | “fixed daily morning dose of Human menopausal gonadotrophin (HMG) Merional® intra-muscular injection” NCT02640976 ↗ |